/IKING T H E R A P E U T I C S Corporate Presentation February 2021 Forward-Looking Statements This presentation contains statements about our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks relating to: both our and our col ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2020 Earnings Conference Call February 17, 2021 4:30 PM ET Company Participants Stephanie Diaz – Manager-Investor Relations Brian Lian – President and Chief Executive Officer Greg Zante – Chief Financial Officer Conference Call Participants Derek Archila – Stifel Joon Lee – Truist Securities Michael Morabito – Chardan Capital Markets Matt Luchini – BMO Capital Steve Seedhouse – Raymond James Julian Harrison – BTIG Andy Hsieh – William Blair Yale Jen – Laidlaw & Co. ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2020 Earnings Conference Call October 28, 2020 4:30 PM ET Company Participants Stephanie Diaz - Investor Relations, Brian Lian - President and Chief Executive Officer Greg Zante - Senior Vice President, Finance Conference Call Participants Joon Lee - Truist Securities Derek Archila - Stifel Ryan Deschner - Raymond James Mathew Luchini - BMO Michael Morabito - Chardan Capital Markets David Bautz - Zacks Yale Jen - Laidlaw & Company Jay Olson - Oppenheimer Andy Hsieh ...

IKING HERAPE NOVEL TI FOR METABO ENDOCRINE DISORDER Corporate Presentation August 2020 Forward-Looking Statements 2 This presentation contains statements about our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks relating to: ...

IKING E R A P E U T I C S NOVEL TI FOR METABO ENDOCRINE DISORDER Corporate Presentation July 2020 Forward-Looking Statements 2 This presentation contains statements about our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks r ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2020 Results Earnings Conference Call July 29, 2020 4:30 PM ET | --- | |----------------------------------------------| | | | Company Participants | | Stephanie Diaz - Manager, Investor Relations | | Brian Lian - President and CEO | | Greg Zante - Senior Vice President, Finance | | Conference Call Participants | | Joon Lee - SunTrust | | Michael Morabito - Chardan Capital Markets | | Matt Luchini - BMO Capital | | Steve Seedhouse - Raymond James | | Jay Olson - Opp ...

IKING UTICS E R A P E NOVEL TI FOR METABO ENDOCRINE DISORDER Corporate Presentation May 2020 Forward-Looking Statements 2 This presentation contains statements about our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks relati ...